The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index; none of the 3 sources its claims cite is checked for support yet.
Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program
Open accessAbstract
Liquid chromatography-tandem mass spectrometry (LC-MS-MS) offers specific advantages over gas chromatography-mass spectrometry (GC-MS) such as the ability to identify and measure a broader range of compounds with minimal sample preparation. Comparative analysis of LC-MS-MS versus GC-MS was performed for urinalysis detection of five benzodiazepine compounds currently part of the Department of Defense (DoD) Drug Demand Reduction Program (DDRP) testing panel; alpha-hydroxyalprazolam, oxazepam, lorazepam, nordiazepam and temazepam. In the analyses of internally prepared control urine samples at concentrations around the DDRP administrative decision point for benzodiazepines (100 ng/mL), both technologies produced comparable results with average accuracies between 99.7 and 107.3% and average coefficients of variation (%CV) <9%. Analysis of service member specimens that screened positive for benzodiazepines using both technologies produced comparable results for all analytes. Different degrees of matrix effect were observed for all analytes in the LC-MS-MS analysis. However, the effects were controlled by using deuterated internal standards (ISTDs). Additionally, there was a 39% increase in nordiazepam mean concentration analyzed by LC-MS-MS due to suppression of the ISTD ion by the flurazepam metabolite 2-hydroxyethylflurazepam. The ease and speed of sample extraction, the broader range of compounds that can be analyzed and shorter run time make the LC-MS-MS technology a suitable and expedient alternative confirmation technology for benzodiazepine testing.
Overview
CoChat Summary
TL;DR
LC–MS-MS and GC–MS produced comparable urine benzodiazepine confirmation results for five DDRP panel compounds, with acceptable accuracy and precision around the 100 ng/mL administrative decision point. LC–MS-MS offered easier/faster extraction, shorter run times, and lower LOD/LOQ for some analytes, though a flurazepam metabolite interfered with nordiazepam quantitation.
Key findings
- At concentrations around the DDRP benzodiazepine decision point (100 ng/mL), both methods showed comparable performance: average accuracies between 99.7 and 107.3% and average %CV <9% in internally prepared control urine samples. At 75, 100, and 125 ng/mL, GC–MS average accuracy was 102% with CVs <5%, while LC–MS-MS average accuracy was 105% with CVs <7%; the % difference between methods ranged from 0.14 to 5.07%.
- For LORA, NORD, and TEMA, LC–MS-MS attained lower LOD/LOQ values (1.96–2.15 ng/mL; CVs 3.4–8.1%) than GC–MS (6.13–26.30 ng/mL; CVs 0.4–4.8%). AHAL and OXAZ had equivalent LOD/LOQ values for both technologies.
- LC–MS-MS matrix effects caused target ion enhancement of 2–52% for all analytes except NORD; NORD at 100 ng/mL showed <1% suppression. These effects were controlled with deuterated internal standards, with type C sample accuracies of 98.3–102.5% and CVs <5%.
- The flurazepam metabolite 2-hydroxyethylflurazepam (2HEF) suppressed the NORD ISTD ion by 36% and increased NORD mean concentration by 39% in LC–MS-MS versus GC–MS. TEMA GC–MS analysis failed in 3 of 5 replicates containing club drug mixture, while LC–MS-MS had no such problem. In service member specimens, no significant difference was found between methods for NORD, OXAZ, LORA, and AHAL; TEMA differed significantly (P = 0.025), but the mean percent difference was <3%.
Methods
- Urine samples were analyzed for five benzodiazepines: alpha-hydroxyalprazolam (AHAL), oxazepam (OXAZ), lorazepam (LORA), nordiazepam (NORD), and temazepam (TEMA). Internally prepared controls and sample material were fortified at concentrations including 20, 40, 75, 100, 125, 200, 500, and 1,000 ng/mL; GC–MS used 10 sets and LC–MS-MS used 9 sets of four replicates per target concentration.
- GC–MS used enzymatic hydrolysis, solid-phase extraction, derivatization with MTBSTFA, and selected ion monitoring on Agilent 7890 GC/5975 MS instruments. LC–MS-MS used enzymatic hydrolysis, solid-phase extraction without derivatization, and multiple reaction monitoring on a Waters ACQUITY LC coupled to a Quattro Micro triple quadrupole mass spectrometer.
- Method comparison included LOD/LOQ/ULOL determination, matrix effect assessment by the Matuszewski method, interference testing with 40 ng/mL target analytes plus 5,000 ng/mL interferants, and side-by-side analysis of anonymized service member urine specimens that screened positive for benzodiazepines by immunoassay (Nov 2012–Jul 2013). Statistical analyses used Excel 2010 and Minitab 17, including regression ANOVA and Student’s t-tests.
Limitations
- The paper does not include a formal limitations section.
- Evident from the text: the NORD interference by 2HEF occurred at 5,000 ng/mL, which the authors note was 125 times greater than the sample concentration and higher than literature suggests would be physiologically realistic; the authors still recommend considering this effect during method development if the same parent and transition ions are chosen.
- Evident from the text: TEMA GC–MS analysis failed in 3 of 5 club-drug-mixture replicates, and TEMA results differed significantly between technologies (P = 0.025), although the mean percent difference was <3%. Some service member specimen comparisons had small sample sizes (LORA n = 7; AHAL n = 8).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 2 Not checked · 40 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of service member specimens that screened positive for benzodiazepines using both technologies produced comparable results for all analytes.”
- Also stated in: § Conclusion · plain
“Analysis of service member specimens that screened positive for benzodiazepines using both technologies produced comparable results for all analytes.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Different degrees of matrix effect were observed for all analytes in the LC–MS-MS analysis.”
- Also stated in: § Conclusion · plain
“Different degrees of ME were observed for all analytes in the LC–MS-MS analysis.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For AHAL and OXAZ, the LOD and LOQ values were equivalent for both technologies.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, TEMA results differed significantly between technologies (P = 0.025), however the mean percent difference between both technologies was found to be <3% (data analysis not shown).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GC–MS and LC–MS-MS measured mean concentrations for LORA and NORD differed more than 10% when 2HEF was fortified into 40 ng/mL of these analytes.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 42 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 11
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Materials and methods
“A total of ten independent batches of four replicates of sample material for each analyte concentration were analyzed by GC–MS and LC–MS-MS.”
§ Results and discussion
“Independent sets of samples containing four replicates of the target concentrations: 20, 40, 75, 100, 125, 200, 500 and 1,000 ng/mL were analyzed by GC–MS (10 sets) and LC–MS-MS (9 sets)”
Citations
Cites
Matuszewski, B. K., Constanzer, M. L., & Chavez-Eng, C. M. (2003) · Analytical Chemistry · doi:10.1021/ac020361s · Cited by 5,335
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703 · cited 1×
“Additionally, benzodiazepines are often used in combination with illicit drugs to enhance their effects making them a target for drug abuse monitoring programs (3, 4).”
BackgroundPrinciples of Forensic Toxicology
(2020) · Springer eBooks · doi:10.1007/978-3-030-42917-1 · Cited by 385
Benzodiazepine use among injecting drug users: problems and implications
Darke, S. G. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb00909.x · Cited by 51 · cited 1×
“Additionally, benzodiazepines are often used in combination with illicit drugs to enhance their effects making them a target for drug abuse monitoring programs (3, 4).”
BackgroundStout, P. R., Bynum, N. D., Mitchell, J. M., Baylor, M. R., & Ropero-Miller, J. D. (2009) · Journal of Analytical Toxicology · doi:10.1093/jat/33.8.398 · Cited by 29 · cited 2×
“in human urine (1, 5), there are currently no studies that compare the performance of these two analytical methods in the detection and analysis of benzodiazepines.”
BackgroundMethodStout, P. R., Bynum, N. D., Lewallen, C. M., Mitchell, J. M., Baylor, M. R., & Ropero‐Miller, J. D. (2010) · Journal of Analytical Toxicology · doi:10.1093/jat/34.8.430 · Cited by 17 · cited 1×
“in human urine (1, 5), there are currently no studies that compare the performance of these two analytical methods in the detection and analysis of benzodiazepines.”
BackgroundConcentrations of phenobarbital, flurazepam, and flurazepam metabolites in autopsy cases
Ferrara, S., Tedeschi, L., Marigo, M., & Castagna, F. (1979) · Journal of Forensic Sciences · doi:10.1520/jfs10790j · Cited by 9
Cited by
Analytical techniques for the determination of acetaminophen: A review
Montaseri, H., & Forbes, P. B. C. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.08.023 · Cited by 138
Hamd, W. S., Daher, E. A., Tofa, T. S., & Dutta, J. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.885614 · Cited by 123
Abdelrahman, M., Burritt, D. J., & Tran, L. P. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.06.020 · Cited by 114
Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches
Chen, L., Zhong, F., & Zhu, J. (2020) · Metabolites · doi:10.3390/metabo10090348 · Cited by 90
“Meanwhile, UHPLC/HPLC-MS gained popularity in hybrid approaches because of its quicker and less extensive extraction procedures and ability to identify and measure a broader range of compounds [49,50].”
BackgroundKumar, A., Green, K. M., & Rawat, M. (2024) · Foods · doi:10.3390/foods13182937 · Cited by 117
Metadata
- Authors
- Perez, E. R., Knapp, J. A., Horn, C. K., Stillman, S. L., Evans, J. E., & Arfsten, D. P.
- Affiliations
- United States Department of the Navy (US)
- Corresponding author
- Arfsten, Darryl P.
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-10
- Volume
- 40
- Issue
- 3
- Pages
- 201-207
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- PMC
- PMC4885916
- OpenAlex
- W2299389374
- Cited by
- 106
- References
- 7
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 20 · 2020: 15 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 1
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Journal of Analytical Toxicology (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Life Sciences › Agricultural and Biological Sciences › Food Science › Pesticide Residue Analysis and Safety
- Keywords
- benzodiazepines, LC-MS/MS, gas chromatography-mass spectrometry, urine analysis, oxazepam, lorazepam, nordiazepam, temazepam, matrix effects, deuterated internal standards, confirmatory drug testing
- MeSH terms
- Benzodiazepines, Chromatography, Liquid, Humans, Gas Chromatography-Mass Spectrometry, Tandem Mass Spectrometry, Limit of Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program. https://app.cochat.ai/papers/10.1093/jat/bkv140
- The paper
- Perez, E. R., Knapp, J. A., Horn, C. K., Stillman, S. L., Evans, J. E., & Arfsten, D. P. (2016). Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkv140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.